NEW YORK (GenomeWeb) – Belgian diagnostics firm OncoDNA said today that it has signed an agreement under which its tumor profiling products and services will be offered in the Russian Federation by Genext.

Under the deal, Genext will market and distribute OncoDNA's OncoDeep solid tumor test; its OncoTrace and OncoSelect liquid biopsy tests; its OncoStrat&Go solid and liquid biopsy combination; and its OncoKDM data interpretation and reporting software.

Additional terms were not disclosed.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The data generated by 100,000 Genomes Project is being housed on military servers due to attacks by hackers, Naked Security reports.

Vox reports that the United Nations' Convention on Biological Diversity decided against a gene drive moratorium.

A new poll finds most US adults are not familiar with personalized medicine, according to HealthDay.

In Science this week: sequencing of neuroblastomas uncovers alterations linked to prognosis, and more.

Dec
12
Sponsored by
Illumina

This webinar will discuss the use of shotgun metagenomics to identify children at risk of hospital-acquired infection.